PET-CT
DeviceNaF PET-CT
NCT Number: NCT02876731
Prospective, monocentric, comparative, non randomised
Primary objective :
- to compare the diagnostic accuracy of sodium fluoride PET-CT and MRI using the conventional block and diffusion sequence in the search for bone metastases
Secondary objectives :
* compare accuracy of MRI diffusion and conventional MRI * explore the evolution of the results of the different types of imaging over time or under treatment for patients with repeated examinations at 6 months
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Prospective, monocentric, comparative, non randomised.
Organization of NaF PET-CT and MRI on the same day or within a 10 days period.
At 6 months :
Scheduled Project inclusion duration of 36 months (possible adaptation of duration in order to obtain the number of required patients)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
NaF PET-CT
DWMRI
Time frame: Up to 38 months
Institut Jean-Godinot
Other
Comparison of NaF PET-CT and Diffusion MRI in the Diagnosis of Bone Metastases
Acronym: IMMETAOS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05510908
AIDS Related Lymphoma, AIDS-Related Kaposi Sarcoma
La Jolla, California, United States
View Trial DetailsNCT07766252
Cancer, Neoplasms
College Station, Texas, United States
View Trial DetailsNCT01445483
Brain Diseases, Brain Metastasis
Bethesda, Maryland, United States
View Trial DetailsNCT01498276
Cancer, Cardiovascular Diseases
Washington D.C., District of Columbia, United States
View Trial Details